TCM
Teza Capital Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $841K | Buy |
4,529
+177
| +4% | +$32.9K | 0.63% | 27 |
|
|
2025
Q1 | $912K | Buy |
4,352
+2,945
| +209% | +$617K | 0.42% | 67 |
|
|
2024
Q4 | $250K | Sell |
1,407
-3,629
| -72% | -$645K | 0.04% | 393 |
|
|
2024
Q3 | $995K | Buy |
5,036
+3,629
| +258% | +$717K | 0.11% | 259 |
|
|
2024
Q2 | $241K | Buy |
+1,407
| New | +$241K | 0.03% | 499 |
|
|
2024
Q1 | – | Sell |
-18,884
| Closed | -$2.93M | – | 548 |
|
|
2023
Q4 | $2.93M | Buy |
18,884
+14,032
| +289% | +$2.17M | 0.49% | 42 |
|
|
2023
Q3 | $723K | Sell |
4,852
-48,455
| -91% | -$7.22M | 0.12% | 244 |
|
|
2023
Q2 | $7.18M | Buy |
+53,307
| New | +$7.18M | 1.17% | 6 |
|
|
2023
Q1 | – | Sell |
-3,241
| Closed | -$524K | – | 488 |
|
|
2022
Q4 | $524K | Buy |
+3,241
| New | +$524K | 0.1% | 314 |
|
|
2022
Q1 | – | Sell |
-20,012
| Closed | -$2.71M | – | 398 |
|
|
2021
Q4 | $2.71M | Buy |
20,012
+16,154
| +419% | +$2.19M | 0.73% | 28 |
|
|
2021
Q3 | $416K | Sell |
3,858
-53,076
| -93% | -$5.72M | 0.2% | 156 |
|
|
2021
Q2 | $6.41M | Buy |
+56,934
| New | +$6.41M | 1.04% | 5 |
|
|
2021
Q1 | – | Sell |
-6,728
| Closed | -$721K | – | 457 |
|
|
2020
Q4 | $721K | Sell |
6,728
-19,123
| -74% | -$2.05M | 0.41% | 73 |
|
|
2020
Q3 | $2.26M | Buy |
+25,851
| New | +$2.26M | 1.33% | 4 |
|
|
2018
Q3 | – | Sell |
-10,872
| Closed | -$1.01M | – | 355 |
|
|
2018
Q2 | $1.01M | Buy |
10,872
+229
| +2% | +$21.2K | 0.15% | 236 |
|
|
2018
Q1 | $1.01M | Buy |
10,643
+2,479
| +30% | +$235K | 0.24% | 164 |
|
|
2017
Q4 | $790K | Buy |
+8,164
| New | +$790K | 0.48% | 88 |
|
|
2017
Q2 | – | Sell |
-14,201
| Closed | -$925K | – | 2 |
|
|
2017
Q1 | $925K | Buy |
+14,201
| New | +$925K | 0.27% | 117 |
|